Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications

Cancer immunotherapy has shown impressive anti-tumor activity in patients with advanced and early-stage malignant tumors, thus improving long-term survival. However, current cancer immunotherapy is limited by barriers such as low tumor specificity, poor response rate, and systemic toxicities, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Peijie, Han, Jun, Gong, Yanju, Liu, Chao, Yu, Han, Xie, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612242/
https://www.ncbi.nlm.nih.gov/pubmed/36297426
http://dx.doi.org/10.3390/pharmaceutics14101990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612242/
https://www.ncbi.nlm.nih.gov/pubmed/36297426
http://dx.doi.org/10.3390/pharmaceutics14101990

Ejemplares similares